Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Contraceptive Drug & Devices Market Growth of 4.3% CAGR by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: Actavis, Bayer, Church & Dwight - Research and Markets

Research and Markets
Posted on: 16 Sep 16

Research and Markets has announced the addition of the "Global Contraceptive Drug & Devices Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022" report to their offering.

The global contraceptive market is estimated to grow with a CAGR of 4.3% during 2016-2022. These drugs or devices interfere with the normal process of ovulation, fertilization and implantation to prevent the pregnancy; and also, inhibits sexually transmitted diseases.

The global contraceptive market is majorly driven by various factors such as growing prevalence of sexually transmitted diseases (STDs), such as HIV and syphilis with a large chunk of population suffering from such diseases around the world, with the number is increasing every day.

The initiatives taken by various governments and NGOs across the globe to encourage and promote the usage of contraceptives drugs and devices with the primary focus on reducing the rate of population growth; and also, to control the spread of various STDs is the key factor that has provided impetus to the growth of this market.

The global contraceptive market is segmented into two categories namely, drugs and devices. The contraceptive drugs can be further categorized on the basis of its application into three different forms i.e. pills, injectable and patches. Injectable are projected to be segment with the highest growth owing to lesser side effects of injectable over the oral contraceptives and lesser failure rates.

Companies Mentioned:

  • Actavis, Inc.
  • Bayer AG
  • Church & Dwight Co., Inc.
  • Coopersurgical, Inc.
  • Hll Lifecare Limited
  • Mankind
  • Mayer Laboratories, Inc.
  • Merck & Co., Inc.
  • Pace Pharmaceuticals, Inc.
  • Pfizer, Inc.
  • Reckitt Benckiser Plc
  • TEVA Pharmaceutical Industries Ltd.
  • The Female Health Company

Report Structure:

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Geographical Analysis

6. Company Profiles

For more information about this report visit

Related Topics: Women's Health

View source version on

Business Wire

Last updated on: 16/09/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.